Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Total Liabilities (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Total Liabilities for 16 consecutive years, with $55.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities rose 5.23% to $55.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $55.9 million, a 5.23% increase, with the full-year FY2024 number at $50.9 million, up 23.29% from a year prior.
  • Total Liabilities was $55.9 million for Q3 2025 at Xtant Medical Holdings, up from $55.0 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $55.9 million in Q3 2025 to a low of $23.2 million in Q3 2021.
  • A 5-year average of $37.0 million and a median of $34.3 million in 2023 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: tumbled 74.38% in 2021, then surged 60.35% in 2023.
  • Xtant Medical Holdings' Total Liabilities stood at $23.8 million in 2021, then rose by 9.45% to $26.1 million in 2022, then skyrocketed by 58.35% to $41.3 million in 2023, then grew by 23.29% to $50.9 million in 2024, then rose by 9.95% to $55.9 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Total Liabilities are $55.9 million (Q3 2025), $55.0 million (Q2 2025), and $52.0 million (Q1 2025).